Cerebral venous outflow profiles are associated with the first pass effect in endovascular thrombectomy.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 30 07 2021
accepted: 24 10 2021
pubmed: 10 11 2021
medline: 19 10 2022
entrez: 9 11 2021
Statut: ppublish

Résumé

Recent studies found that favorable venous outflow (VO) profiles are associated with higher reperfusion rates after mechanical thrombectomy (MT) in patients with acute ischemic stroke due to large vessel occlusion (AIS-LVO). Fewer retrieval attempts and first-pass revascularization during MT lead to better functional outcomes. To examine the hypothesis that favorable VO profiles assessed on baseline CT angiography (CTA) images correlate with successful vessel reperfusion after the first retrieval attempt and fewer retrieval attempts. A multicenter retrospective cohort study of patients with AIS-LVO treated by MT. Baseline CTA was used to determine the cortical vein opacification score (COVES). Favorable VO was defined as COVES ≥3. Primary outcomes were successful with excellent vessel reperfusion status, defined as Thrombolysis in Cerebral Infarction (TICI) 2b/3 and 2c/3 after first retrieval attempt. 617 patients were included in this study, of whom 205 (33.2%) had first pass reperfusion. In univariate analysis, ordinal COVES (p=0.011) values were significantly higher in patients with first pass than in those with non-first pass reperfusion, while the number of patients exhibiting favorable pial arterial collaterals using the Maas scale on CTA did not differ (p=0.243). In multivariable logistic regression analysis, higher COVES were independently associated with TICI 2b/3 (OR=1.25, 95% CI 1.1 to 1.42; p=0.001) and TICI 2c/3 (OR=1.2, 95% CI 1.04 to 1.36; p=0.011) reperfusion after one retrieval attempt, controlling for penumbra volume and time from symptom onset to vessel reperfusion. Favorable VO, classified as higher COVES, is independently associated with successful and excellent first pass reperfusion in patients with AIS-LVO treated by endovascular thrombectomy.

Sections du résumé

BACKGROUND BACKGROUND
Recent studies found that favorable venous outflow (VO) profiles are associated with higher reperfusion rates after mechanical thrombectomy (MT) in patients with acute ischemic stroke due to large vessel occlusion (AIS-LVO). Fewer retrieval attempts and first-pass revascularization during MT lead to better functional outcomes.
OBJECTIVE OBJECTIVE
To examine the hypothesis that favorable VO profiles assessed on baseline CT angiography (CTA) images correlate with successful vessel reperfusion after the first retrieval attempt and fewer retrieval attempts.
METHODS METHODS
A multicenter retrospective cohort study of patients with AIS-LVO treated by MT. Baseline CTA was used to determine the cortical vein opacification score (COVES). Favorable VO was defined as COVES ≥3. Primary outcomes were successful with excellent vessel reperfusion status, defined as Thrombolysis in Cerebral Infarction (TICI) 2b/3 and 2c/3 after first retrieval attempt.
RESULTS RESULTS
617 patients were included in this study, of whom 205 (33.2%) had first pass reperfusion. In univariate analysis, ordinal COVES (p=0.011) values were significantly higher in patients with first pass than in those with non-first pass reperfusion, while the number of patients exhibiting favorable pial arterial collaterals using the Maas scale on CTA did not differ (p=0.243). In multivariable logistic regression analysis, higher COVES were independently associated with TICI 2b/3 (OR=1.25, 95% CI 1.1 to 1.42; p=0.001) and TICI 2c/3 (OR=1.2, 95% CI 1.04 to 1.36; p=0.011) reperfusion after one retrieval attempt, controlling for penumbra volume and time from symptom onset to vessel reperfusion.
CONCLUSIONS CONCLUSIONS
Favorable VO, classified as higher COVES, is independently associated with successful and excellent first pass reperfusion in patients with AIS-LVO treated by endovascular thrombectomy.

Identifiants

pubmed: 34750110
pii: neurintsurg-2021-018078
doi: 10.1136/neurintsurg-2021-018078
pmc: PMC9606492
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1056-1061

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JJH reports consulting for Medtronic and MicroVention and medical and scientific advisory board membership for iSchemaView. GWA reports equity and consulting for iSchemaView and consulting from Medtronic. JF reports membership of the editorial board of this journal.The other authors report no conflicts.

Références

Stroke. 2021 May;52(5):1761-1767
pubmed: 33682452
J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1055-1059
pubmed: 32934109
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
Lancet. 2000 May 13;355(9216):1670-4
pubmed: 10905241
Eur J Neurol. 2021 Dec;28(12):4109-4116
pubmed: 34424584
Stroke. 2019 Mar;50(3):632-638
pubmed: 30726184
Stroke. 2011 Mar;42(3):693-9
pubmed: 21233472
J Neurointerv Surg. 2015 Aug;7(8):559-63
pubmed: 24962453
Radiology. 2018 Feb;286(2):643-650
pubmed: 28799861
Stroke. 2018 Mar;49(3):660-666
pubmed: 29459390
J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1710-1717
pubmed: 30878371
J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):625-9
pubmed: 18077482
Neurology. 2021 May 5;:
pubmed: 33952649
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
J Cereb Blood Flow Metab. 2017 Feb;37(2):671-682
pubmed: 26965242
Stroke. 2021 Jan;52(2):482-490
pubmed: 33467875
Stroke. 2009 Sep;40(9):3001-5
pubmed: 19590055
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
AJNR Am J Neuroradiol. 2015 Feb;36(2):289-94
pubmed: 25324493
Curr Opin Neurol. 2015 Feb;28(1):1-3
pubmed: 25490198

Auteurs

Noel van Horn (N)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany no.vanhorn@uke.de.

Jeremy J Heit (JJ)

Department of Radiology, Stanford University School of Medicine, Stanford, California, USA.

Reza Kabiri (R)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Marius M Mader (MM)

Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany.

Soren Christensen (S)

Department of Neurology and Neurological Sciences, Stanford, Stanford, California, USA.

Michael Mlynash (M)

Department of Neurology and Neurological Sciences, Stanford, Stanford, California, USA.

Gabriel Broocks (G)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Lukas Meyer (L)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jawed Nawabi (J)

Department of Radiology, Charité School of Medicine and University Hospital Berlin, Berlin, Germany.

Maarten G Lansberg (MG)

Department of Neurology and Neurological Sciences, Stanford, Stanford, California, USA.

Gregory W Albers (GW)

Department of Neurology and Neurological Sciences, Stanford, Stanford, California, USA.

Max Wintermark (M)

Department of Radiology, Stanford University School of Medicine, Stanford, California, USA.

Jens Fiehler (J)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Tobias D Faizy (TD)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Radiology, Stanford University School of Medicine, Stanford, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH